Abstract #3913

Hyperpolarized [1-13C]Pyruvate Imaging Predicts Survival in Rat C6 Glioma Model

Keshav Datta¹, Mette H. Lauritzen¹, Milton Merchant², Taichang Jang², Shie-Chau Liu¹, Ronald D. Watkins ¹, Ralph E. Hurd¹, Lawrence Recht², and Daniel M. Spielman¹

¹Department of Radiology, Stanford University, Stanford, CA, United States, ²Department of Neurology, Stanford University, Stanford, CA, United States

The [1-¹³C]Lactate/[1-¹³C]Bicarbonate ratio at 48 hrs post-treatment, as measured in a hyperpolarized [1-¹³C]Pyruvate experiment, was found to accurately predict the survival in rat C6 glioma model treated with a single dose of the anti-VEGF drug Bevacizumab.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.